1 |
Adamis AP, Meklir B, Joyce NC. In situ injury-induced release of basic-fibroblast growth factor from corneal epithelial cells. Am J Pathol 1991; 139: 961-967
|
2 |
King TV, VaIlee BL. Neovascularisation of the meniscus with angiogenin. An experimental study in rabbits. J Bone Joint Surg Br 1991; 73: 587-590
|
3 |
Ryffel B, Weber E, Mihatsch MJ. Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin. Exp Nephrol 1994; 2: 324-333
|
4 |
Schott RJ, Morrow LA. Growth factors and angiogenesis. Cardiovasc Res 1993; 27: 1155-1161
DOI
ScienceOn
|
5 |
Vezina C, Kudelski A, Sehgal SN. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo) 1975; 28: 721-726
DOI
|
6 |
Khaw PT, Doyle JW, Sherwood MB, Grierson I, Schultz G, McGorray S. Prolonged localized tissue effects from 5-minute exposures to fluorouracil and mitomycin C. Arch Ophthalmol 1993; 111: 263-267
DOI
ScienceOn
|
7 |
Khaw PT, Doyle JW, Sherwood MB, Smith MF, McGorray S. Effects of intraoperative 5-tluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit. Arch Ophthalmol 1993; 100: 367-372
|
8 |
Lipman RM, Epstein RJ, Hendricks RL. Suppression of corneal neovascularization with cyclosporine. Arch Ophthalmol 1992; 110: 405-407
DOI
ScienceOn
|
9 |
Baker H, Sidorowicz A, Sehgal SN, Vezina C. Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation. J Antibiot (Tokyo) 1978; 31: 539-545
DOI
|
10 |
Epstein RJ, Stulting RD, Hendricks RL, Harris DM. Corneal neovascularization. Pathogenesis and inhibition. Cornea 1987; 6: 250-257
DOI
ScienceOn
|
11 |
Soncin F. Angiogenin supports endothelial and fibroblast ceIl adhesion. Proc Natl Acad Sci USA 1992; 89: 2232-2236
DOI
ScienceOn
|
12 |
Sturrock ND, Lang CC, Struthers AD. Cyclosporin-induced nephrotoxicity and hypertension. Br J Hosp Med 1992; 48: 483-485
|
13 |
Hill JC, Maske R. An animal model for corneal graft rejection in high-risk keratoplasty. Transplantation 1988; 46: 26-30
DOI
ScienceOn
|
14 |
Koch AE, Polverini PJ, Kunkel SL, et al. InterIeukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-1801
DOI
|
15 |
Martel RR, Klicius J, Galet S. Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can J Physiol Pharmacol 1977; 55: 48-51
DOI
ScienceOn
|
16 |
Jimi S, Ito K, Kohno K, Ono M, Kuwano M, Itagaki Y, Ishikawa H. Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells. Biochem Biophys Res Commun 1995; 211: 476-483
DOI
ScienceOn
|
17 |
Yamamoto T, Varani J, Soong HK, Lichter PR. Effects of 5-fluorouracil and mitomycin C on cultured rabbit subconjunctival fibroblasts. Ophthalmology 1990; 97: 1204-1210
|
18 |
Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP. Requirement for vascular endothelial growth factor in woundand inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci 1998; 39: 18-22
|
19 |
Olsen TW, Benegas NM, Joplin AC, Evangelista T, Mindrup EA, Holland EJ. Rapamycin inhibits corneal allograft rejection and neovascularization. Arch Ophthalmol 1994; 112: 1471-1475
DOI
ScienceOn
|
20 |
Calne RY, Collier DS, Lim S, Pollard SG, Samaan A, White DJ, Thiru S. Rapamycin for immunosuppression in organ allografting. Lancet 1989; 22: 227
DOI
ScienceOn
|
21 |
Hu G, Riordan JF, Vallee BL. Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc Natl Acad Sci USA 1994; 91: 12096-12100
DOI
ScienceOn
|
22 |
Shin SH, Kim JC, Chang SI, Lee H, Chung SI. Recombinant kringle 1-3 of plasminogen inhibits rabbit corneal angiogenesis induced by angiogenin. Cornea 2000; 19: 212-217
DOI
ScienceOn
|